The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease

American Heart Journal

Volumn 151, Issue 2, 2006, Pages 514-521

  Nigam, Anil ^a   Bourassa, Martial G ^a   Fortier, Annik ^a   Guertin, Marie Claude ^a   Tardif, Jean Claude ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; OBESITY; PRIORITY JOURNAL; STROKE; WORLD HEALTH ORGANIZATION;

ANALYSIS OF VARIANCE; CORONARY DISEASE; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REGISTRIES; RISK FACTORS; STATISTICS;

EID: 31344441239     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.03.050     Document Type: Article

References (30)

1. H.C. McGill, A. McMahan, and E.E. Herderick Obesity accelerates the progression of coronary atherosclerosis in young men Circulation 105 2002 2712 2718
2. The DECODE Study Group Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 26 2003 688 696
3. L.E. Eberly, J. Stamler, and J.D. Neaton Relation of triglyceride levels, fasting and nonfasting, to fatal and nonfatal coronary heart disease Arch Intern Med 163 2003 1077 1083
4. S.M. Grundy, G.J. Balady, and M.H. Criqui Primary prevention of coronary heart disease: guidance from Framingham. A statement for healthcare professionals from the AHA Task Force on Risk Reduction Circulation 97 1998 1876 1887
5. A. Rosengren, S. Hawken, and S. Ounpuu Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study Lancet 364 2004 953 962
6. H.M. Lakka, D.E. Laaksonen, and T.A. Lakka The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men JAMA 288 2002 2709 2716
7. B. Isomaa, P. Almgren, and T. Tuomi Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 2001 683 689
8. M. Trevisan, J. Liu, and F.B. Bahsas Syndrome X and mortality: a population-based study. Risk factor and life expectancy research group Am J Epidemiol 148 1998 958 966
9. J.A. Suwaidi, R.S. Wright, and J.P. Grill Obesity is associated with premature occurrence of acute myocardial infarction Clin Cardiol 24 2001 542 547
10. T.D. Rea, S.R. Heckbert, and R.C. Kaplan Body mass index and the risk of recurrent coronary events following acute myocardial infarction Am J Cardiol 88 2001 467 472
11. R. Wolk, P. Berger, and R.J. Lennon Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease Circulation 108 2003 2206 2211
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
13. K.G. Alberti, and P.Z. Zimmet Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 1998 539 553
14. B. Balkau, and M.A. Charles Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR) Diabet Med 16 1999 442 443
15. D.E. Laaksonen, H.-M. Laaka, and L.K. Niskanen Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study Am J Epidemiol 156 2002 1070 1077
16. National Center for Health Statistics Prevalence of overweight and obesity among adults: United States, 1999 2002 Centers for Disease Control Hyatsville, MD Available at http://www.cdc.gov/nchs/products/pubs/pubd/hestats/ obese/obse99t2.htm [accessed September 4, 2003]
17. E.S. Ford, W.H. Giles, and W.H. Dietz Prevalence of the metabolic syndrome among US adults: findings from the third national health and nutrition examination survey JAMA 287 2002 356 359
18. O.C. Marroquin, K.E. Kip, and D.E. Kelley Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women. A report from the women's ischemia syndrome evaluation Circulation 109 2004 714 721
19. K.J. Mukamal, R.W. Nesto, and M.C. Cohen Impact of diabetes on long-term survival after acute myocardial infarction Diabetes Care 24 2001 1422 1427
20. D. Aguilar, S.D. Solomon, and L. Kober Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction. The Valsartan in Acute Myocardial Infarction (VALIANT) Trial Circulation 110 2004 1572 1578
21. J.L. Anderson, B.D. Horne, and H.U. Jones Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease Cardiology 101 2004 185 193
22. G. Arcaro, A. Cretti, and S. Balzano Insulin causes endothelial dysfunction in humans: sites and mechanisms Circulation 105 2002 576 582
23. H. Tezcan, D. Yavuz, and A. Toprak Effect of angiotensin-converting enzyme inhibition on endothelial function and insulin sensitivity in hypertensive patients J Renin Angiotensin Aldosterone Syst 4 2003 119 123
24. J.M. Olefsky, J.W. Farquhar, and G.M. Reaven Reappraisal of the role of insulin in hypertriglyceridemia Am J Med 57 1974 551 560
25. P.W.F. Wilson, R.B. D'Agostino, and D. Levy Prediction of coronary heart disease using risk factor categories Circulation 97 1998 1837 1847
26. S.M. Grundy Obesity, metabolic syndrome and coronary atherosclerosis Circulation 105 2002 2696 2698
27. P.M. Ridker, J.E. Buring, and N.R. Cook C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. An 8-year follow-up of 14 719 initially healthy American women Circulation 107 2003 391 397
28. S. Konstantinides, K. Schäfer, and S. Koschnick Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity J Clin Invest 108 2001 1533 1540
29. G. De Pergola, and N. Pannacciulli Coagulation and fibrinolysis abnormalities in obesity J Endocrinol Invest 25 2002 899 904
30. S. Rashid, K.D. Uffelman, and G.F. Lewis The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant states J Diabetes Complications 16 2002 24 28